BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21555747)

  • 1. Balancing the risks and benefits of proton pump inhibitors.
    Gill JM; Player MS; Metz DC
    Ann Fam Med; 2011; 9(3):200-2. PubMed ID: 21555747
    [No Abstract]   [Full Text] [Related]  

  • 2. Proton pump inhibitors: the good, the bad, and the unwanted.
    Chubineh S; Birk J
    South Med J; 2012 Nov; 105(11):613-8. PubMed ID: 23128806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dyspepsia and reflux. Systematic literature review from SBU].
    Von Holstein CS; Norlund A
    Lakartidningen; 2007 May 2-8; 104(18):1414-7. PubMed ID: 17550016
    [No Abstract]   [Full Text] [Related]  

  • 4. When proton pump inhibitors fail.
    Kahrilas PJ
    Clin Gastroenterol Hepatol; 2008 May; 6(5):482-3. PubMed ID: 18378500
    [No Abstract]   [Full Text] [Related]  

  • 5. Addicted to acid suppression.
    Hanauer SB
    Nat Rev Gastroenterol Hepatol; 2009 Sep; 6(9):497. PubMed ID: 19713979
    [No Abstract]   [Full Text] [Related]  

  • 6. Proton pump inhibitors: a better prescription is needed.
    Khara HS; Pitchumoni CS
    J Clin Gastroenterol; 2009 Jul; 43(6):597-8. PubMed ID: 19384247
    [No Abstract]   [Full Text] [Related]  

  • 7. Proton pump inhibitor side effects and drug interactions: much ado about nothing?
    Madanick RD
    Cleve Clin J Med; 2011 Jan; 78(1):39-49. PubMed ID: 21199906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors: balancing the benefits and potential fracture risks.
    Richards JB; Goltzman D
    CMAJ; 2008 Aug; 179(4):306-7. PubMed ID: 18695170
    [No Abstract]   [Full Text] [Related]  

  • 9. The Effect of Proton Pump Inhibitors on Barrett's Esophagus.
    Dunbar KB; Souza RF; Spechler SJ
    Gastroenterol Clin North Am; 2015 Jun; 44(2):415-24. PubMed ID: 26021202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
    Freedberg DE; Kim LS; Yang YX
    Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent acid inhibition: summary of the evidence and clinical application.
    Mearin F; Ponce J
    Drugs; 2005; 65 Suppl 1():113-26. PubMed ID: 16335865
    [No Abstract]   [Full Text] [Related]  

  • 12. A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors.
    Yu LY; Sun LN; Zhang XH; Li YQ; Yu L; Yuan ZQ; Meng L; Zhang HW; Wang YQ
    Adv Ther; 2017 May; 34(5):1070-1086. PubMed ID: 28429247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.
    Gyawali CP
    Curr Gastroenterol Rep; 2017 Sep; 19(9):46. PubMed ID: 28780717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs for peptic ulcer disease and GERD.
    Treat Guidel Med Lett; 2011 Sep; 9(109):55-60; quiz 2 p following 60. PubMed ID: 21860368
    [No Abstract]   [Full Text] [Related]  

  • 15. Proton Pump Inhibitors and Bone Health: What the Orthopaedic Surgeon Needs to Know.
    Wagner SC
    JBJS Rev; 2018 Dec; 6(12):e6. PubMed ID: 30562209
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-Term PPI Use: Balancing Potential Harms and Documented Benefits.
    Laine L; Nagar A
    Am J Gastroenterol; 2016 Jul; 111(7):913-5. PubMed ID: 27113114
    [No Abstract]   [Full Text] [Related]  

  • 17. Omerprazole and other proton pump inhibitors: pharmacology, efficacy, and safety, with special reference to use in children.
    Israel DM; Hassall E
    J Pediatr Gastroenterol Nutr; 1998 Nov; 27(5):568-79. PubMed ID: 9822325
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison table: Drugs for GERD and peptic ulcer disease.
    Med Lett Drugs Ther; 2018 Jan; 60(1538):e16-e18. PubMed ID: 29309400
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease.
    Park JH; Lee J; Yu SY; Jung JH; Han K; Kim DH; Rhee J
    BMC Geriatr; 2020 Oct; 20(1):407. PubMed ID: 33059626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiota in Reflux Esophagitis and Peptic Ulcer Disease.
    Rescigno M
    Surg Infect (Larchmt); 2023 Apr; 24(3):245-249. PubMed ID: 37010961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.